← All trials
NCT04552093
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 9, 2020
- Primary completion
- Jun 30, 2022
- Completion date
- Dec 31, 2022
- First posted
- Sep 17, 2020
- Last posted
- Sep 17, 2020
- Enrollment
- 31
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Netherlands Cancer InstituteLead sponsor
- Netherlands Cancer InstituteOverall official - principal investigator
- Erasmus University RotterdamCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.